It obviously good for NEU shareholders but sad for family that would have been hopeful to see success.
I am curios if anyone with great research capabilities has information on how well there drug performed in pre-clinical studies.
OVID FAIL, page-3
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.06 |
Change
0.305(2.22%) |
Mkt cap ! $1.757B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.82 | $278.2K | 20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 526 | $14.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.08 | 262 | 5 |
View Market Depth
| Last trade - 10.10am 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |